ArticleCureus2025
Role of Transesophageal Echocardiography in the Surgical Treatment of Malignant Thrombosis of the Superior Vena Cava.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is a case of malignant superior vena cava thrombosis successfully treated during open surgical treatment. A 70-year-old woman presented in the emergency department for edema of the head, neck, eyelids, and upper limbs and dyspnea. The CT scan and CT arteriography showed an obstruction in the venous drainage in the superior vena cava associated with a mediastinal mass, a histotype B malignant thymoma. Therefore, radical surgical resection with correction of the superior vena cava thrombosis was performed. Preoperative transesophageal echocardiography showed pericardial effusion on the inferior apical level with a thickened pericardium. A thrombus was completely occluding the superior vena cava lumen, projecting toward the superior-anterior side of the right atrium, directed toward the right appendage. Cardiopulmonary bypass cannulation was carefully placed using ultrasound guidance to not invade the thrombotic mass, avoiding further embolic events. The postoperative transesophageal echocardiography showed that the thrombus was effectively removed, and the stabilization of the superior vena cava wall was successful. The right appendage was free from thrombosis, similar to the superior vena cava, and pericardial effusion was absent. In this framework, advanced monitoring is fundamental, making neurological, respiratory, and hemodynamic assessments important. As we could not employ the Swan-Ganz catheter given the anatomic obstacle, the transesophageal echocardiographic assessment was mandatory both for hemodynamic monitoring and surgical guidance. It has a role in assessing patients with complete occlusion of the superior vena cava, severe refractory symptoms, and potential thrombosis of venous collaterals. With improved anesthesiology and perioperative advanced monitoring, surgical procedures can be performed safely and effectively in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.